# GE HealthCare Technologies Inc. – Consensus ‘buy’ rating and 35.3% Upside Potential - Link: https://www.directorstalkinterviews.com/ge-healthcare-technologies-inc.consensus-buy-rating-and-35.3-upside-potential/4121127827 - Published: 2023-09-20T13:27:07+01:00 - Author: Charlotte Edwards **GE HealthCare Technologies Inc.** which can be found using ticker (GEHC) now have 9 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 99 and 78 with the average target price sitting at $89.67. Given that the stocks previous close was at $66.28 this is indicating there is a potential upside of 35.3%. Also worth taking note is the 50 day moving average now sits at $73.02 and the 200 moving average now moves to $74.00. The total market capitalization for the company now stands at 30.07B. The stock price for the company is currently 66.12 USD The potential market cap would be $40,686,870,692 based on the market consensus. The company has a dividend yield of 0.77%. Other points of data to note are a P/ E ratio of 18.32, revenue per share of 41.86 and a 5.77% return on assets. GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry. Share on: